Inhaled insulin vs injected insulin for exercise blood sugar drops in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether a new inhaled insulin (Technosphere) causes fewer low blood sugar episodes during exercise compared to standard injected insulin in people with type 1 diabetes who use an automated insulin pump. It may help you avoid hypoglycemia while staying active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have type 1 diabetes and use a Tandem t:slim X2 or Tandem Mobi pump with Control-IQ for at least 3 months.
- You use insulin aspart or insulin lispro in your pump.
- Your total daily insulin dose is between 20 and 80 units.
- You usually need 12 units or less of insulin for a 50-gram carbohydrate lunch.
- You exercise at least 3 times a week for 30 minutes or more (moderate or vigorous intensity).
- You do not smoke, vape, or use marijuana within the last 3 months.
- You do not have asthma, COPD, or other serious lung disease.
- You have not had severe hypoglycemia or diabetic ketoacidosis in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if exercising before breakfast (while fasting) helps improve blood sugar control and heart health in people with type 1 diabetes. You'll continue using your insulin pump and glucose monitor, and attend supervised exercise sessions and MRI scans to measure changes in your body.
This trial compares two ways of setting your insulin pump (SmartGuard vs Temp Target) during anaerobic exercise, like weightlifting or sprinting. It aims to see which setting keeps your blood sugar more stable, helping you exercise safely with type 1 diabetes.
This study observes how well the Control-IQ insulin pump system works for teenagers with type 1 diabetes who exercise at least twice a week. It aims to see if the technology is safe and effective during regular physical activity.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.